CXCL8 and ovarian carcinoma: Receiver operating characteristic (ROC) curves generated from the early stage ovarian cancer patient cohort demonstrated IL-8 autoantibodies to have a similar sensitivity (65.5%) to that of IL-8 (62.6%) at 98% specificity.